Curetopia: Eradicating Rare Diseases with Community-Driven Medicine
Join us this Thursday Feb 13 for an AMA with Curetopia, a new BioDAO pioneering community-driven rare disease drug development.
Curetopia is a new Biotech Decentralized Autonomous Organization (BioDAO) that partners with patients & patient families to accelerate cures in the $1T+ rare disease space.
Led by visionary biotech founder Ethan Perlstein (YC alum and Harvard PhD) who successfully brought a rare disease drug to Phase 3 trial with $5M (vs. the typical $100M+ costs) and has been partnering with patient communities to cure rare diseases for over 10 years.
Curetopia's Mission is to:
• Eradicate the 10,000+ rare diseases often overlooked by mainstream biopharma companies.
• Empower patients to influence research and vote on research funding using the $CURES token.
• Incentivize global researcher and patient communities to contribute research and participate in trials and experiments.
By decentralizing the governance, development and commercialization of rare disease drugs, Curetopia is pioneering a new form of community-driven medicine where patient and patient families are in control.
Learn more about SpineDAO:
• Curetopia Website
• Join the community on Telegram
• Read the Vision Paper
• Follow Curetopia on X
• Curetopia on the Bio Launchpad